Skip to main content
Telehealth GLOW An editorial reading of the GLOW research-peptide blend (GHK-Cu + BPC-157 + TB-500) — three components, three pathways, one unverified stack.

CH.0 / CONTACT CHANNEL

editorial corrections welcome

Send a citation that was missed, a correction, or a research-literature question. This is not a clinical contact form and cannot answer prescribing or product questions.

What we can answer

Corrections. Missing or mis-cited references. Suggestions for newly-indexed papers that should appear in a future revision of the /research or /references pages. Questions about the methodology described on /about. Permission requests to quote or excerpt (generally granted for non-commercial use with attribution; please ask before any commercial use).

What we cannot answer

Medical questions about whether GLOW or any of its components is appropriate for anyone. Prescribing questions. Compounding-pharmacy questions. Sourcing or vendor questions. Telehealth referrals. Dosing questions framed as personal advice. Product complaints or returns (nothing is sold here).

This is a reading of the research literature, not a clinician and not a vendor. Routine product, prescribing, and dosing questions belong with a licensed healthcare provider in your jurisdiction. The line at the bottom of every page applies to every interaction here as well.

Reach the editor

Use the form below for the categories above. Replies are best-effort and may take several days. No personal health information is collected or stored; please send none. Messages are treated as correspondence about the pages — a correction or citation may have its substance folded (without identifying you) into a future revision.

Form fields: Name (optional), Email (required for reply), Subject (required), Message (required, 5000 characters max). The form posts to a generic email endpoint. No backend account is created.